Merck KGaA's French Unit Under Further Investigations, AFP Reports
October 19 2022 - 4:32AM
Dow Jones News
--A French subsidiary of pharmaceutical company Merck KGaA is
facing further investigations in France for potentially misleading
information related to a change in formula of its thyroid
medication Levothyrox, news agency AFP reports.
--The unit said investigations aren't related to the quality of
the new formula but communications related to the change in 2017,
AFP reports.
--Shares in Merck KGaA are down 4% at EUR164.70.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
October 19, 2022 05:17 ET (09:17 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Sep 2023 to Sep 2024